Stargazer Pharmaceuticals is Drug Discovery in United States that focus on retinal degenerative disease business. Founded in 2018. They cover business area such as operator, a focus, rare disease, Stargardt Disease, an inherit retinal degenerative disease, no treatment, healthcare professional, new therapeutic.
2018
( 8 years old in 2026 )
Retinal Degenerative Disease
-
200 Clarendon Street
Floor 45, Mailbox 30
Boston, MA 02215
United States
Private
operatora focusrare diseaseStargardt Diseasean inherit retinal degenerative diseaseno treatmenthealthcare professionalnew therapeutic
* We use standard office opening hours in near Stargazer Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stargazer Pharmaceuticals is Drug Discovery business from United States that founded in 2018 (8 years old in 2026), Stargazer Pharmaceuticals business is focusing on Retinal Degenerative Disease.
Stargazer Pharmaceuticals headquarter office and corporate office address is located in 200 Clarendon Street Floor 45, Mailbox 30 Boston, MA 02215 United States.
Stargazer Pharmaceuticals was founded in United States.
In 2026, Stargazer Pharmaceuticals is currently focus on retinal degenerative disease sector.
Above is snippet of Google Trends for "retinal degenerative disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stargazer Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
